NARA Discovery
Article Details
← Back to Search Results
Journal Article

Novel insights into eugenol anaesthesia in poeciliid larvae: Preliminary study of gill histology

María C. Vercellini; Ramiro Rearte; Ana Carranza‐Martín; Matías H. Assandri; Silvina Vargas; Martin M. Montes; Miguel A. Ayala
Journal of Fish Biology · Vol. 109, Issue 1 · pp. 37-44 · 2026

Abstract

The increasing use of fish in research emphasizes the need for effective and safe anaesthetic protocols, particularly for early life stages. Eugenol has been proposed as a promising anaesthetic, yet information regarding its effects on Cnesterodon decemmaculatus larvae remains scarce. This study assessed anaesthesia and recovery times, as well as gill tissue integrity, in larvae exposed to different eugenol concentrations. A randomized controlled trial was conducted using four treatment groups (6, 12.5, 25 and 50 mgL −1 ) and a control group (10 mgL −1 ethanol). Significant differences were observed in both anaesthesia and recovery times across treatments ( p p ≤ 0.02), and filament perimeter was also significantly reduced in all treatments ( p −1 exhibited significantly more necrotic foci than controls ( p −1 , decreased at 12.5 and 25 mgL −1 ( p −1 ( p p ≥ 0.08). However, oedema was higher at 6 mgL −1 than at 12.5 mgL −1 ( p = 0.02), and congestion was lower at 12.5 mgL −1 than 25 mgL −1 ( p = 0.04). Overall, the results indicate that 12.5 mgL −1 eugenol provides effective anaesthesia with minimal histological alterations, representing the optimal concentration for use in C. decemmaculatus larvae.

Bibliographic Information

JournalJournal of Fish Biology
PublisherWiley
Publication Date2026-07-01
Publication Year2026
Volume109
Issue1
Pages37-44
Document TypeJournal Article
Print ISSN0022-1112
eISSN1095-8649
DOI10.1111/jfb.70378
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/10958649
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.